Events

At this event Professor Andreas Bergthaler, Head of Institute of Hygiene and Applied Immunology, Medical University of Vienna presents About the role of CD8 T cells in energy trade-offs across organs.

About Professor Andreas Bergthaler

Andreas Bergthaler studied veterinary medicine at the University of Veterinary Medicine in Vienna. For his graduate studies, he joined the Institute of Experimental Immunology at the ETH and University of Zurich (Professors Hans Hengartner and Nobel laureate Rolf Zinkernagel). After postdoctoral work in the laboratory of Professor Daniel Pinschewer at the University of Geneva, he worked with Professor Alan Aderem at the Institute for Systems Biology in Seattle. From 2011 to 2021, Andreas Bergthaler developed his own independent research group as CeMM principal investigator. In January 2022, he became professor of molecular immunology at MedUni Vienna and remains CeMM adjunct principal investigator. The Bergthaler laboratory pursues two main research directions: 1) Dissection of the molecular interplay of inflammation and metabolism on an organismal level. Here, a particular focus rests on the enigmatic multi-organ disease cachexia, which affects many patients suffering from chronic infections, terminal cancer, or autoinflammatory diseases. 2) Development of advanced pathogen surveillance on the population level. To this end, new approaches and analytic tools are developed to detect pathogens in wastewater and air filters and to inform public health decisions. Andreas Bergthaler is the recipient of an ERC Starting Grant and several awards including the Loffler-Frosch-Prize of the Society of Virology. He cofounded several companies including the clinical stage company Hookipa Pharma, which develops immunotherapies for infectious and malignant diseases.